DAX22.983 +1,8%ESt505.403 +1,4%Top 10 Crypto11,71 +4,5%Dow40.814 -1,3%Nas17.303 -2,0%Bitcoin76.375 +2,2%Euro1,0896 +0,4%Öl70,30 +0,2%Gold2.997 +0,3%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 Tesla A1CX3T NVIDIA 918422 RENK RENK73 HENSOLDT HAG000 NEL ASA A0B733 thyssenkrupp 750000 Daimler Truck DTR0CK Siemens Energy ENER6Y Amazon 906866 BMW 519000 PUMA 696960 Allianz 840400 Palantir A2QA4J Volkswagen (VW) vz. 766403
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX mit klaren Gewinnen -- Dow fester erwartet -- Daimler Truck: Gewinnrückgang -- BMW mit Margeneinbruch -- HUGO BOSS, Goldpreis, PUMA im Fokus
Top News
Mercedes-Benz-Aktie höher: Mercedes-Chef sieht seinen Autobauer fast so amerikanisch wie US-Unternehmen Mercedes-Benz-Aktie höher: Mercedes-Chef sieht seinen Autobauer fast so amerikanisch wie US-Unternehmen
Jefferies & Company Inc. bescheinigt Buy für Hannover Rück-Aktie Jefferies & Company Inc. bescheinigt Buy für Hannover Rück-Aktie
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil
Wer­bung
5 % Cashback: Teste finanzen.net ZERO und sichere Dir 5 % Cashback auf Deinen ETF-Sparplan – JETZT informieren!

Edwards Lifesciences Aktie

NeuKaufenVerkaufen
Aktien-Sparplan anlegen
62,65 EUR +0,49 EUR +0,79 %
FSE
67,96 USD -0,53 USD -0,77 %
BTT
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.37,12 Mrd. EUR

KGV31,67Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKN936853

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS28176E1082

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolEW

Edwards Lifesciences Aktien News

DatumMeistgelesen
BusinesswireEdwards Lifesciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference
PR NewswireEW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit with the Schall Law Firm
PR NewswireEW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit
Wer­bungEdwards Lifesciences-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
PR NewswireEW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit
PR NewswireThe Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Edwards Lifesciences Corporation(EW) Shareholders
BusinesswireEdwards Lifesciences Outlines Growth Strategy at Annual Investor Conference
PR NewswireLevi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Edwards Lifesciences Corporation(EW) Shareholders
PR NewswireShareholders of Edwards Lifesciences Corporation Should Contact The Gross Law Firm Before December 13, 2024 to Discuss Your Rights - EW
PR NewswireEW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit with the Schall Law Firm
PR NewswireEW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit
PR NewswireInvestors in Edwards Lifesciences Corporation Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
PR NewswireEW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit with the Schall Law Firm
PR NewswireThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 13, 2024 in Edwards Lawsuit - EW
PR NewswireEW INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
PR NewswireEW INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
PR NewswireEW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit with the Schall Law Firm
PR NewswireThe Gross Law Firm Notifies Shareholders of Edwards Lifesciences Corporation(EW) of a Class Action Lawsuit and an Upcoming Deadline
PR NewswireEW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit
PR NewswireEW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit
PR NewswireEW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit with the Schall Law Firm
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Edwards Lifesciences Corporation - EW
BusinesswireEdwards Lifesciences to Host Earnings Conference Call on October 24, 2024
PR NewswireEIN-JAHRES-DATEN ZEIGEN HERVORRAGENDE ERGEBNISSE FÜR DAS CORDELLA PULMONALARTERIEN-SENSORSYSTEM VON ENDOTRONIX
PR NewswireONE-YEAR DATA SHOW EXCELLENT OUTCOMES FOR ENDOTRONIX CORDELLA PULMONARY ARTERY SENSOR SYSTEM
BusinesswireEdwards Lifesciences to Present at the 2024 Wells Fargo Healthcare Conference
BusinesswireEdwards Lifesciences Expands Structural Heart Portfolio With Acquisitions of JenaValve and Endotronix
BusinesswireEdwards Lifesciences to Host Earnings Conference Call on July 24, 2024
PR NewswireBD to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion to Expand Smart Connected Care Solutions and Become an Advanced Monitoring Technology Leader
BusinesswireEdwards Lifesciences to Host Earnings Conference Call on April 25, 2024
BusinesswireEdwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference
BusinesswireEdwards Lifesciences to Host Earnings Conference Call on February 6, 2024
PR NewswireCLASP IID ONE-YEAR DATA CONFIRM SAFETY AND EFFICACY OF EDWARDS PASCAL SYSTEM FOR DEGENERATIVE MITRAL REGURGITATION
PR NewswireTRISCEND II SIX-MONTH DATA FOR FIRST 150 PATIENTS SUCCESSFULLY DEMONSTRATE SAFETY AND EFFICACY OF EDWARDS EVOQUE SYSTEM FOR SEVERE TRICUSPID REGURGITATION
PR NewswireEDWARDS LIFESCIENCES REPORTS THIRD QUARTER RESULTS
PR NewswireFIVE-YEAR DATA FROM PARTNER 3 TRIAL DEMONSTRATE EXCELLENT SURVIVAL FOR PATIENTS RECEIVING EDWARDS SAPIEN 3 VALVE
PR NewswireEDWARDS EVOQUE TRANSCATHETER TRICUSPID VALVE REPLACEMENT SYSTEM RECEIVES CE MARK
PR NewswireEDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON OCTOBER 25, 2023
PR NewswireEDWARDS LIFESCIENCES TO PRESENT AT THE 2023 WELLS FARGO HEALTHCARE CONFERENCE
PR NewswireEDWARDS LIFESCIENCES REPORTS SECOND QUARTER RESULTS
PR NewswireEDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON JULY 26, 2023
Wer­bung

Edwards Lifesciences News

Edwards Lifesciences News: auf dieser Seite finden Sie alle Edwards Lifesciences News und Nachrichten zur Edwards Lifesciences Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Edwards Lifesciences News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Edwards Lifesciences News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.